Avidity Biosciences, founded in San Diego, California, is a biotechnology company focused on developing novel antibody oligonucleotide conjugates (AOCs) to revolutionize RNA therapeutics. Their core mission is to profoundly improve lives by addressing the root causes of serious diseases through their innovative AOC platform. Initially targeting muscle diseases, Avidity Biosciences aims to unlock the potential of oligonucleotides for a broad range of medical conditions.
Notable figures associated with Avidity Biosciences include key scientific leaders and investors from the biotech industry. The company has achieved significant milestones, including advancing its muscle disease programs and expanding its innovative pipeline. Avidity Biosciences' impact is marked by its commitment to transforming RNA therapeutics, potentially offering groundbreaking treatments for previously intractable diseases.
